{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:37:49Z","timestamp":1793198269198,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2024.114003","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:26:57Z","timestamp":1736936817000},"page":"114003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Analysis of the efficacy of Langhans giant cells in controlling cutaneous Mycobacterium marinum infections"],"prefix":"10.1016","volume":"148","author":[{"given":"Zhenzhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohui","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-9776","authenticated-orcid":false,"given":"Chaojiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-5053","authenticated-orcid":false,"given":"Hongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.114003_b0005","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00069-18","article-title":"Cutaneous mycobacterial infections","volume":"32","author":"Franco-Paredes","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2024.114003_b0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2340\/00015555-3283","article-title":"Cutaneous tuberculosis and nontuberculous mycobacterial infections at a national specialized hospital in China","volume":"99","author":"Mei","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.intimp.2024.114003_b0015","article-title":"Treatment of non-tuberculosis mycobacteria skin infections","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.114003_b0020","article-title":"Drug resistance in nontuberculous mycobacteria: mechanisms and models","volume":"10","author":"Saxena","year":"2021","journal-title":"Biology (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.114003_b0025","first-page":"S55","article-title":"Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis","volume":"56","author":"Laudone","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.intimp.2024.114003_b0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2024.114003_b0035","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.15252\/embr.201744121","article-title":"Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells","volume":"18","author":"Gharun","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2024.114003_b0040","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357070","article-title":"Multinucleation resets human macrophages for specialized functions at the expense of their identity","volume":"24","author":"Ahmadzadeh","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2024.114003_b0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jid.2020.01.026","article-title":"Cellular, molecular, and immunological characteristics of Langhans multinucleated giant cells programmed by IL-15","volume":"140","author":"Wang","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.114003_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011387","article-title":"The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas","volume":"19","author":"Cleverley","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.114003_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis Infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.intimp.2024.114003_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.114003_b0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tim.2019.08.005","article-title":"The case for modeling human infection in zebrafish","volume":"28","author":"Gomes","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.intimp.2024.114003_b0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00281-015-0522-4","article-title":"Protection and pathology in TB: learning from the zebrafish model","volume":"38","author":"Meijer","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2024.114003_b0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4939-6673-8_20","article-title":"Murine Mycobacterium marinum infection as a model for tuberculosis","volume":"1535","author":"Lienard","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2024.114003_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.102839","article-title":"5-aminolevulinic acid-photodynamic therapy ameliorates cutaneous granuloma by killing drug-resistant Mycobacterium marinum","volume":"38","author":"Yang","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.intimp.2024.114003_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetimm.2016.08.015","article-title":"Multinucleated giant cell cytokine expression in pulmonary granulomas of cattle experimentally infected with Mycobacterium bovis","volume":"180","author":"Palmer","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.intimp.2024.114003_b0090","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1053\/j.gastro.2020.08.019","article-title":"S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants","volume":"159","author":"Willers","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2024.114003_b0095","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.114003_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040519","article-title":"A structural perspective on calprotectin as a ligand of receptors mediating inflammation and potential drug target","volume":"12","author":"Garcia","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2024.114003_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151952","article-title":"Multinucleated giant cell phenotype in response to stimulation","volume":"225","author":"Trout","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2024.114003_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305158","article-title":"Exploring cytokine dynamics in tuberculosis: a comparative analysis of patients and controls with insights from three-week antituberculosis intervention","volume":"19","author":"Krivo\u0161ov\u00e1","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.114003_b0115","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2024e13755","article-title":"Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease","volume":"57","author":"Zhao","year":"2024","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924025256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924025256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:56:18Z","timestamp":1740617778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924025256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"alternative-id":["S1567576924025256"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.114003","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the efficacy of Langhans giant cells in controlling cutaneous Mycobacterium marinum infections","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.114003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114003"}}